Genting Bhd’s Unsuccessful Bid to Privatise Genting Malaysia (GENM)
Genting Bhd’s attempt to privatise Genting Malaysia (GENM) ended unsuccessfully, reaching 73.13% acceptances, short of the 75% threshold required for delisting. The offer expired on Dec 1, coinciding with positive news that GENM’s US subsidiary secured a full-casino licence in New York—a development that analysts say highlights GENM’s undervalued future prospects.
Why the Privatisation Failed
-
The offer price—about 10% above GENM’s pre-offer trading price—was widely viewed as unattractive, especially by long-term investors whose entry costs were higher.
-
Analysts argued the bid underestimated GENM’s future value, particularly given:
-
The new New York casino licence
-
Overseas expansion prospects
-
Potential asset revaluations
-
Possible non-gaming divestments
-
GENM’s fragmented minority shareholder base made a higher acceptance rate harder to achieve.
-
Under Malaysian takeover rules, Genting cannot acquire more than 2% of GENM shares for 12 months without a waiver, making another quick privatisation attempt unlikely.
New York Casino Licence: A Major Catalyst
The New York Gaming Facility Location Board approved all three full-casino licences, including Genting New York’s RWNYC, making it:
RWNYC plans include:
-
Expansion from 400 to 2,000 hotel rooms
-
11–15 million expected annual visitors
-
Up to 800 gaming tables and 6,000 slot machines by 2029
Market Reaction
Despite the positive licence news:
Analysts, however, maintain optimism:
-
GENM trades below its historical price-to-book ratio
-
Kenanga maintains a RM3 target price and “outperform” call
-
Asset restructuring is seen as a future catalyst
Funding and Expansion Outlook
The New York project will cost US$4–5 billion, though the funding gap has narrowed to US$1–2 billion thanks to:
-
Improved earnings outlook from being NYC’s sole full-service casino
-
Potential monetisation of Miami land (previously valued near US$1.2 billion)
-
Possible sale of 270 million treasury shares
-
Ability to issue up to 10% new shares without triggering a rights issue
Big Picture
Although the privatisation attempt failed, analysts see significant long-term upside for GENM. The company benefits from strengthened overseas prospects—especially in New York—and maintains regulatory transparency as a publicly listed entity, which many minority investors prefer.
Thank you